ASC Therapeutics Doses First Patient with ASC618 Gene Therapy
29 Nov 2023 //
BUSINESSWIRE
Charles River, ASC Therapeutics to Scale Manufacturing of 2nd Gen Gene Therapy
13 Jun 2022 //
BUSINESSWIRE
ASC Therapeutics Joins U.S. Consortium of Gene Therapy Partners
24 May 2022 //
BUSINESSWIRE
ASC Tx Announces Podium, Poster Presentations of IND-Enabling Studies for ASC618
16 May 2022 //
BUSINESSWIRE
ASC Tx Receives Key Regulatory Designations in U.S. and Europe for Hemophilia A
29 Mar 2022 //
BUSINESSWIRE